$MORF

Entry price: 32.66

Fundamentals:

- Sector: Medical - Biotech

- EPS % Chg (Last Qtr): 157%

- EPS % Chg (Previous Qtr): -68%

- 3 Year EPS Growth Rate: 0%

- EPS Est % Chg (Current Yr): 0%

- Sales % Chg (Last Qtr): 354%

- Sales % Chg (Previous Qtr): 38%

- 3-Year Sales Growth Rate: 167%

- Annual Pre -Tax Margin: -249.8%

Kommentar:

Added
Average price: 31.71

Kommentar:

--------------------------------
EPS % Chg (Last Qtr): 14%
Sales % Chg (Last Qtr): 164%

Kommentar:

Sold at 74.50
Return: +134.95%

Kommentar: